| First Author | Jeng KS | Year | 2020 |
| Journal | Int J Mol Sci | Volume | 21 |
| Issue | 11 | PubMed ID | 32471201 |
| Mgi Jnum | J:302323 | Mgi Id | MGI:6508215 |
| Doi | 10.3390/ijms21113796 | Citation | Jeng KS, et al. (2020) Liver Fibrosis and Inflammation under the Control of ERK2. Int J Mol Sci 21(11):3796 |
| abstractText | Chronic liver injury could lead the formation of liver fibrosis, eventually some would develop to hepatocellular carcinoma (HCC), one of the leading malignancies worldwide. The aim of the study is to dissect the role of extracellular signal-regulated kinase 2 (ERK2) signaling in liver fibrosis and inflammation. The choline-deficient, ethionine-supplemented (CDE) diet could lead to fatty livers and generate oval cells, activate hepatocyte stellate cell (HSC) and recruit immune cells as the liver fibrosis model mice. WT and ERK2 deficient (ERK2(-/-)) mice were compared in terms of liver weight/body weight, liver function, liver fibrosis markers and the differential gene expression in hepatotoxicity. ERK2(-/-) mice display the less degree of liver fibrosis when compared to WT mice. The protein level of alpha smooth muscle (alpha-SMA) was reduced and several hepatocellular carcinoma-related genes such as MMP9, FoxM1 were down-regulated. In addition, the cell proliferation and the percentages of activated T cells were reduced in ERK2(-/-) mice upon liver injury. Therefore, ERK2 plays an important role in regulating liver cirrhosis and inflammation. |
